Jenny Hill is a public health epidemiologist with an MSc in Medical Parasitology from the London School of Hygiene & Tropical Medicine and a PhD on the delivery, access and use of interventions to control malaria in pregnancy in sub-Saharan Africa from the University of Amsterdam. In her early career she worked for UNICEF over a period of seven years to develop community-based malaria control programmes as part of broader child survival programmes in Kenya, Uganda, Zambia, northern Namibia and Botswana. She joined LSTM in 1995, previously as Deputy Director of the DFID-funded Malaria Consortium (to 2004) and then as Project Manager of the Gates-funded MiP Consortium and also Principle Investigator leading the Public Health Impact theme (to 2016). She is currently Senior Programme Manager in the Malaria Epidemiology unit lead by Professor Feiko ter Kuile, managing a portfolio of grants including the IMPROVE trials co-funded by EDCTP and MRC/DFID/WT Joint Global Health Trials Scheme. She currently holds research grants from EDCTP (IMPPACT project), WWARN/Oxford (MiP Scientific Group) and PATH.
Research interests focus on strategies for optimizing the delivery of malaria control interventions which target vulnerable groups - in particular pregnant women and young children – involving integrated approaches to service delivery. Current projects include policy research on the translation of research evidence generated by the Malaria in Pregnancy Consortium into policy and practice (IMPPACT project); acceptability, feasibility and cost effectiveness studies of new strategies to prevent malaria in pregnancy in Kenya, Malawi, and Tanzania as part of the IMPROVE trials; and a longitudinal study to document and explore the dynamics of the implementation of the world’s first malaria vaccine, RTS,S/AS01 in western Kenya (Kenya HUS study).
Member of the Roll Back Malaria Working Group on Malaria in Pregnancy (2006-present)
Member of the Roll Back Malaria Working Group on Insecticide treated nets (1999-present)
Current research grants:
The Dynamics of Healthcare Utilization in the Context of RTS,S/AS01 Vaccine Introduction in Kenya (HUS), PATH Seattle (01/02/2018-30/06/2021). Principal Investigator.
Malaria in Pregnancy Scientific Group, World-wide Antimalarial Resistance Network (WWARN), Oxford (01/09/2017-31/08/2020). Principle Investigator.
Maximising the public health impact of interventions to control malaria in pregnancy through the translation of EDCTP-funded evidence-based global policies to country level policies and plans
EDCTP (01/012016-31/12/2018). Principal Investigator.
IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in HIV-infected pregnant women in Kenya and Malawi: a multi-centre 3-arm placebo-controlled trial (IMPROVE-2). EDCTP/MRC/DFID/WT (01/07/2017-30/11/2020). Co-Investigator & Principle Investigator of sub-studies on Acceptability, feasibility and cost effectiveness.
Intermittent preventive therapy (IPTp) with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in pregnancy in high sulphadoxine-pyrimethamine resistance areas in Kenya, Malawi, and Tanzania (IMPROVE). EDCTP (1/12/2016-30/11/2020). Co-Investigator & Principle Investigator of sub-studies on Acceptability, feasibility and cost effectiveness.